CARL logo

CARLSMED INC

CARLNASDAQ
🏆 #3176 by market capUS Equity
$14.08▼ $0.08 (−0.60%)
After hours · at close
🔔
Track CARL
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.6%
7d▼ 8.5%
14d▼ 7.6%
30d▼ 16.8%
ytd▲ 14.3%
1y▲ 4.6%
🏦Market Cap
$383M
Small Cap
📈Revenue Growth (YoY)
+85.9%
High Growth
📊Gross Margin
76.6%
High
💵FCF Margin
-54.0%
Thin
⚖️P/S Ratio
6.1x
Fair
Otter Score
76
Good

Trading Snapshot

Day Range
$14.02 – $14.27
52-Week Range
$8.50 – $17.23
Volume
$3.09B
Avg Volume
$3.91B
Shares Outstanding
27.2M
Next Earnings
Dec 12, 2026

Fundamentals Snapshot

Annual Revenue
$51M
Last Q Revenue
$19M
P/E Ratio
-10.4
P/S Ratio
6.1x
EPS (TTM)
$-1.34
Dividend Yield
0.00%
Dilution (1yr)
−46.4%

Why Investors Own CARL

  • ✓High-growth profile — revenue up +16.7% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 65% gross margin and 30% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CARL logo

CARLSMED INC

CARL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$51M▲ +85.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
75.3%▲ +2.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$31M▲ +26.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$30M▲ +15.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
14.2M▼ −46.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$68M▲ +$45M YoY
StockOtter · stockotter.space

About CARLSMED INC

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
76/100

Analyst Price Target

ⓘ
Average Target
$15.31
▲ +8.8% Upside
High Target$16.98
Low Target$13.88
Based on 13 analysts

Latest News & Updates

🚀
Reuters·2h ago

CARLSMED INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift CARL price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

CARLSMED INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.